The IPO premium has slipped to ₹48, down from ₹108 just a few days ago. While the stock is still expected to see decent listing…

As per Shaily Engineering’s annual report for financial year 2025, Dr. Reddy’s is listed among the top clients for the company within the pharmaceutical sector.

Railtel’s growth during the quarter was led by the project work services business, which, however, is a low margin business.

Announcement of the next five-year strategy plan post the fourth quarter of this fiscal and a potential resolution of the Hyderabad Metro project by FY26-end…

Such a move will be positive for Indian drugmakers such as Biocon, Dr. Reddy’s Laboratories, Lupin and Sun Pharma, who have exposure to the biosimilars…

Sunteck Realty’s Dubai-based wholly-owned subsidiary inked an agreement to appoint the majority of directors on the board of its JV company and inked another one…

Citi has maintained its “sell” rating on the stock with a price target of ₹990. It said that the Revlimid generic-led drag will be tough…

Q2 Results LIVE Updates: Over 40 companies are reporting their results on the fourth day of this earnings-heavy week. The markets will first react to…

Backed by Peak XV Partners, Sequoia Capital, and Tiger Global, Groww is targeting a valuation of about ₹61,736 crore, which would make it larger than…

Sensex Today | Stock Market LIVE Updates: Infra major L&T reacts to results that missed estimates due to extended monsoons, while HPCL, LIC Housing Finance,…